Header cover image

Investing Ideas
/
Chinese Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows

Chinese Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows

Results

10

1 new

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

10 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	688266 Suzhou Zelgen BiopharmaceuticalsLtd	CN¥67.89	-0.1%	42.8%	CN¥17.7b	CN¥79.00	PS36.8x	E125.6%	n/a
	688046 GemPharmatech	CN¥13.72	0.1%	-30.0%	CN¥5.7b	CN¥16.75	PE40.2x	E27.9%	0.4%
	603707 Nanjing King-Friend Biochemical PharmaceuticalLtd	CN¥14.33	-3.3%	1.8%	CN¥23.5b	CN¥18.00	PS6x	E70.5%	0.7%
	688166 BrightGene Bio-Medical Technology	CN¥31.90	-4.9%	-16.7%	CN¥13.6b	CN¥41.11	PE71.6x	E34.8%	0.3%
	002653 Haisco Pharmaceutical Group	CN¥36.20	7.6%	50.8%	CN¥39.6b	CN¥42.38	PE84.3x	E35.7%	0.8%
	300294 New China Resources Boya Bio-pharmaceutical GroupLtd	CN¥32.63	4.2%	1.0%	CN¥16.3b	CN¥36.70	PE88.4x	E44.4%	1.0%
	688278 Xiamen Amoytop Biotech	CN¥73.79	-2.2%	71.7%	CN¥30.2b	CN¥85.76	PE40.5x	E32.0%	0.6%
	301080 AcrobiosystemsLtd	CN¥45.65	1.2%	-32.5%	CN¥5.6b	CN¥47.91	PE50.2x	E29.9%	2.0%
	300357 Zhejiang Wolwo Bio-Pharmaceutical	CN¥23.30	-3.4%	-23.7%	CN¥12.4b	CN¥27.96	PE39.1x	E23.3%	0.8%
	300702 Zhejiang Tianyu Pharmaceutical	CN¥17.24	1.5%	-27.3%	CN¥5.9b	CN¥22.60	PE135.8x	E40.4%	0.3%

Page 1 of 1